Showing results (181-190 of 190) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 190 results.
Melanoma Research|September 1, 1992
Tamoxifen as a single agent for advanced melanoma in postmenopausal women. A phase II study of the EORTC Malignant Melanoma Cooperative GroupP Rümke, U R Kleeberg, R M MacKie, et al.
International Journal of Cancer|August 9, 1995
Risk of cutaneous melanoma associated with a family history of the disease. The International Melanoma Analysis Group (IMAGE)D Ford, J M Bliss, A J Swerdlow, et al.
International Journal of Cancer|September 15, 1976
An examination of the immunology of cancer patientsA J Cochran, R M Mackie, R M Grant, et al.
Human Pathology|April 1, 1991
Histopathologic diagnosis of dysplastic nevi: concordance among pathologists convened by the World Health Organization Melanoma ProgrammeC Clemente, A J Cochran, D E Elder, et al.
International Journal of Cancer|August 9, 1995
Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: systematic overview of 10 case-control studies. The International Melanoma Analysis Group (IMAGE)J M Bliss, D Ford, A J Swerdlow, et al.
Annals of Surgical Oncology|July 14, 2000
Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experienceN Cascinelli, F Belli, M Santinami, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Validity of the histopathological criteria used for diagnosing dysplastic naevi. An interobserver study by the pathology subgroup of the EORTC Malignant Melanoma Cooperative GroupP E de Wit, B van't Hof-Grootenboer, D J Ruiter, et al.
Lancet (London, England)|October 19, 1985
Malignant melanoma in Scotland 1979-1983R M MacKie, J F Smyth, D S Soutar, et al.
Anti-Cancer Drugs|September 7, 1999
Heterogeneity of chemosensitivity of metastatic cutaneous melanomaI A Cree, M H Neale, N E Myatt, et al.
Journal of the National Cancer Institute|September 30, 2010
Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL studyF Demenais, H Mohamdi, V Chaudru, et al.
Pageof 19